Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Sleep and CYP2B6[original query] |
---|
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenetics and genomics 2005 Jan 15 (1): 1-5. Rotger Margalida, Colombo Sara, Furrer Hansjakob, Bleiber Gabriela, Buclin Thierry, Lee Belle L, Keiser Olivia, Biollaz Jérôme, Décosterd Laurent, Telenti Amalio, |
Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa. Antiviral therapy 2009 14 (5): 687-95. Cohen Karen, Grant Alison, Dandara Collet, McIlleron Helen, Pemba Lindiwe, Fielding Katherine, Charalombous Salome, Churchyard Gavin, Smith Peter, Maartens Ga |
Sleep quality in efavirenz-treated Chinese HIV patients - comparing between GT and GG genotype of CYP2B6-516 G/T polymorphisms. International journal of STD & AIDS 2014 Mar 25 (3): 193-200. Lee Shui Shan, To Kin Wang, Lee Man Po, Wong Ngai Sze, Chan Denise P C, Li Patrick C K, Cheung Siu Wai, Chan Raphael C |
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC infectious diseases 2013 13 261. Mukonzo Jackson K, Okwera Alphonse, Nakasujja Neoline, Luzze Henry, Sebuwufu Deogratious, Ogwal-Okeng Jasper, Waako Paul, Gustafsson Lars L, Aklillu Ele |
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. BMC pharmacology & toxicology 2015 16 4. Dhoro Milcah, Zvada Simbarashe, Ngara Bernard, Nhachi Charles, Kadzirange Gerald, Chonzi Prosper, Masimirembwa Coll |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: